People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BlinkBio, Inc. | — | Biotechnology | Series B | $43.6M | $20.8M | 2014 |
| Innocrin Pharmaceuticals Holdings, LLC | — | Pharmaceuticals | Series B | $42.1M | $204.0M | 2014 |
| Viamet Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $35.0M | $850.1M | 2009 |
| SpineAlign Medical Inc | — | Other | Series A | $21.6M | $108.0M | 2009 |
Douglas Reed at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Reed on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| S Edward Torres | 2 | 8 |
| James Rosen | 2 | 4 |
| Garheng Kong | 1 | 16 |
| William Moore | 1 | 7 |
| Geoff Smith | 1 | 6 |
| Mark Simon | 1 | 6 |
| FRED ESHELMAN | 1 | 5 |
| Richard Kent | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Alan Lewis | 1 | 4 |
| Derek Small | 1 | 4 |
| Steven Weinstein | 1 | 4 |
| James Schulz | 1 | 3 |
| Lauren T Silverman | 1 | 3 |
| William T. White III | 1 | 3 |
| LAUREN SILVERMAN | 1 | 3 |
| Gary Grenter | 1 | 2 |
| Robert Schotzinger | 1 | 2 |
| Mike Henson | 1 | 2 |
| Patrick Lynn | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.